Pituitary-hormone secretion by thyrotropinomas

Pituitary

Volumn 12, Issue 3, 2009, Pages 200-210

  Roelfsema, Ferdinand ^a   Kok, Simon ^a   Kok, Petra ^a   Pereira, Alberto M ^a   Biermasz, Nienke R ^a   Smit, Jan W ^a   Frolich, Marijke ^a   Keenan, Daniel M ^b   Veldhuis, Johannes D ^c   Romijn, Johannes A ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF VIRGINIA   (United States)

^c MAYO CLINIC   (United States)

Author keywords

Approximate entropy; Deconvolution; Diurnal rhythm; Growth hormone; Hormone secretion; Phase shift; Prolactin; Thyrotropin; Thyrotropinoma; TSH

Indexed keywords

GROWTH HORMONE; OCTREOTIDE; PROLACTIN; SOMATOMEDIN; THYROID HORMONE; THYROTROPIN; THYROXINE;

ACROMEGALY; ADULT; AGED; ARTICLE; CIRCADIAN RHYTHM; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GROWTH HORMONE BLOOD LEVEL; GROWTH HORMONE RELEASE; HORMONE RELEASE; HUMAN; MALE; MATHEMATICAL COMPUTING; PRIORITY JOURNAL; PROLACTIN BLOOD LEVEL; PROLACTIN RELEASE; THYROTROPIN BLOOD LEVEL; THYROTROPIN RELEASE; THYROTROPIN SECRETING ADENOMA; THYROXINE BLOOD LEVEL; TRANSSPHENOIDAL SURGERY; TREATMENT REFUSAL;

ADENOMA; ADULT; AGED; FEMALE; FLUOROIMMUNOASSAY; GROWTH HORMONE; HUMANS; INSULIN-LIKE GROWTH FACTOR I; MALE; MIDDLE AGED; PITUITARY HORMONES; PITUITARY NEOPLASMS; PROLACTIN; RADIOIMMUNOASSAY; THYROTROPIN;

EID: 67849115708     PISSN: 1386341X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11102-008-0159-6     Document Type: Article

References (53)

1. Mariotti S (2006) Normal physiology of the hypothalamo-pituitary-thyroidal system and relation to the neural system and other endocrine gland. Chapter 4 in Thyroid Disease Manager. www.thyroidmanager.com
2. Adriaanse R, Brabant G, Prank K, Endert E, Wiersinga WM (1992) Circadian changes in pulsatile TSH release in primary hypothyroidism. Clin Endocrinol (Oxf) 37:504-510. doi: 10.1111/j.1365-2265.1992.tb01481.x
3. Faber J, Kirkegaard C, Rasmussen B, Westh H, Busch-Sorensen M, Jensen JW (1987) Pituitary-thyroid axis in critical illness. J Clin Endocrinol Metab 65:315
4. Van den Berghe G, De Zegher F, Veldhuis JD, Wouters P et al (1997) Thyrotrophin and prolactin release in prolonged critical illness: dynamics of spontaneous secretion and effects of growth hormone-secretagogues. Clin Endocrinol (Oxf) 47:599. doi: 10.1046/ j.1365-2265.1997.3371118.x
5. Romijn JA, Adriaanse R, Brabant G, Prank K, Endert E, Wiersinga WM (1999) Pulsatile secretion of thyrotropin during fasting: A decrease of thyrotropin pulse amplitude. J Clin Endocrinol Metab 70:1631-1636
6. Kok P, Roelfsema F, Frolich M, Meinders AE, Pijl H (2005) Spontaneous diurnal TSH secretion is enhanced in proportion to circulating leptin in obese premenopausal women. J Clin Endocrinol Metab 90:6185-6191. doi: 10.1210/jc.2005-0003
7. Beck-Peccoz P, Brucker-Davis F, Persani L, Smallridge RC, Weintraub BD (1996) Thyrotropin-secreting pituitary tumors. Endocr Rev 17:610-638. doi: 10.1210/er.17.6.610
8. Van Aken MO, Pereira AM, van den Berg G, Romijn JA, Veldhuis JD, Roelfsema F (2004) Profound amplification of secretory-burst mass and anomalous regularity of ACTH secretory process in patients with Nelson's syndrome compared with Cushing's disease. Clin Endocrinol (Oxf) 60:765-772. doi: 10.1111/j.1365-2265.2004.02052.x
9. Groote Veldman R, van den Berg G, Pincus SM, Frolich M, Veldhuis JD, Roelfsema F (1999) Increased episodic release and disorderliness of prolactin secretion in both micro- and macroprolactinomas. Eur J Endocrinol 140:192-200. doi: 10.1530/eje.0.1400192
10. van den Berg G, Frolich M, Veldhuis JD, Roelfsema F (1994) Growth hormone secretion in recently operated acromegalic patients. J Clin Endocrinol Metab 79:1706-1715. doi: 10.1210/jc.79.6.1706
11. Keenan DM, Roelfsema F, Biermasz N, Veldhuis JD (2003) Physiological control of pituitary hormone secretory-burst mass, frequency and waveform: A statistical formulation and analysis. Am J Physiol Regul Integr Comp Physiol 285:R664-R673
12. Akaike H (1974) A new look at the statistical model identification. IEEE Trans Automat Contr AC-19:716-723. doi: 10.1109/TAC.1974.1100705
13. Pincus SM (2000) Irregularity and asynchrony in biologic network signals. Methods Enzymol 321:149-182. doi: 10.1016/S0076-6879(00)21192-0
14. Hartman ML, Pincus SM, Johnson ML, Matthews DH, Faunt LM, Vance ML, Thorner MO, Veldhuis JD (1994) Enhanced basal and disorderly growth hormone secretion distinguish acromegalic from normal pulsatile growth hormone release. J Clin Invest 94:1277-1288. doi: 10.1172/JCI117446
15. Veldhuis JD, Straume M, Iranmanesh A, Mulligan T, Jaffe C, Barkan A, Johnson ML, Pincus S (2001) Secretory process regularity monitors neuroendocrine feedback and feedforward signaling strength in humans. Am J Physiol Regul Integr Comp Physiol 280:R721-R729
16. Pincus SM, Hartman ML, Roelfsema F, Thorner MO, Veldhuis JD (1999) Hormone pulsatility discrimination via coarse and short time sampling. Am J Physiol 277:E948-E957
17. Van Aken MO, Pereira AM, van Thiel SW, van den Berg G, Frolich M, Veldhuis JD, Romijn JA, Roelfsema F (2005) Irregular and frequent cortisol secretory episodes with preserved diurnal rhythmicity in primary adrenal Cushing's syndrome. J Clin Endocrinol Metab 90:1570-1577. doi: 10.1210/jc.2004-1281
18. Liu PY, Pincus SM, Keenan DM, Roelfsema F, Veldhuis JD (2005) Analysis of bidirectional pattern synchrony of concentration-secretion pairs: implementation in the human testicular and adrenal axes. Am J Physiol Regul Integr Comp Physiol 288:R440-R446. doi: 10.1152/ajpregu.00414.2004
19. Liu PY, Pincus SM, Keenan DM, Roelfsema F, Veldhuis JD (2005) Joint synchrony of reciprocal hormonal signaling in human paradigms of both ACTH excess and cortisol depletion. Am J Physiol Endocrinol Metab 289:E160-E165. doi: 10.1152/ajpendo.00007.2005
20. Keenan DM, Veldhuis JD (2001) Hypothesis testing of the aging male gonadal axis via a biomathematical construct. Am J Physiol 280:R1755-R1771
21. Pincus SM, Mulligan T, Iranmanesh A, Gheorghiu S, Godschalk M, Veldhuis JD (1996) Older males secrete luteinizing hormone and testosterone more irregularly, and jointly more asynchronously, than younger males. Proc Natl Acad Sci USA 93:14100-14105. doi: 10.1073/pnas.93.24.14100
22. Veldhuis JD, Iranmanesh A, Johnson ML, Lizarralde G (1990) Twenty-four hour rhythms in plasma concentrations of adenohypophyseal hormones are generated by distinct amplitude and/or frequency modulation of underlying pituitary secretory bursts. J Clin Endocrinol Metab 71:1616-1623
23. Evans WS, Anderson SM, Hull LT, Azimi PP, Bowers CY, Veldhuis JD (2001) Continuous 24-hour intravenous infusion of recombinant human growth hormone (GH)-releasing hormone-(1-44)-amide augments pulsatile, entropic, and daily rhythmic GH secretion in postmenopausal women equally in the estrogen-withdrawn and estrogen-supplemented states. J Clin Endocrinol Metab 86:700-712. doi: 10.1210/jc.86.2.700
24. Bowers CY, Granda R, Mohan S, Kuipers J, Baylink D, Veldhuis JD (2004) Sustained elevation of pulsatile growth hormone (GH) secretion and insulin-like growth factor I (IGF-I), IGF-binding protein-3 (IGFBP-3), and IGFBP-5 concentrations during 30-day continuous subcutaneous infusion of GH-releasing peptide-2 in older men and women. J Clin Endocrinol Metab 89:2290-2300. doi: 10.1210/jc.2003-031799
25. Veldhuis JD, Bidlingmaier M, Anderson SM, Wu Z, Strasburger CJ (2001) Lowering total plasma insulin-like growth factor I concentrations by way of a novel, potent, and selective growth hormone (GH) receptor antagonist, pegvisomant (B2036-Peg), augments the amplitude of GH secretory bursts and elevates basal/nonpulsatile GH release in healthy women and men. J Clin Endocrinol Metab 86:3304-3310. doi: 10.1210/ jc.86.7.3304
26. Ando S, Sarlis NJ, Krishnan J, Feng X, Refetoff S, Zhang MQ, Oldfield EH, Yen PM (2001) Aberrant alternative splicing of thyroid hormone receptor in a TSH-secreting pituitary tumor is a mechanism for hormone resistance. Mol Endocrinol 15:1529-1538. doi: 10.1210/me.15.9.1529
27. Ando S, Sarlis NJ, Oldfield EH, Yen PM (2001) Somatic mutation of TR beta can cause a defect in negative regulation of TSH in a TSH-secreting pituitary tumor. J Clin Endocrinol Metab 86:5572-5576. doi: 10.1210/ jc.86.11.5572
28. Sanno N, Teramato A, Matsuno A, Takekoshi S, Osamura RY (1995) GH and PRL gene expression by nonradioisotopic in situ hybridization in TSH-secreting pituitary adenomas. J Clin Endocrinol Metab 80:2518-2522. doi: 10.1210/jc.80.8.2518
29. Teramoto A, Sanno N, Tahara S, Osamura YR (2004) Pathological study of thyrotropin-secreting pituitary adenoma: Plurihormonality and medical treatment. Acta Neuropathol 108:147-153. doi: 10.1007/s00401-004-0863-x
30. Gittoes NJ, McCabe CJ, Verhaeg J, Sheppard MC, Franklyn JA (1998) An abnormality of thyroid hormone receptor expression may explain abnormal thyrotropin hormone production in thyrotropin-secreting pituitary tumors. Thyroid 8:9-14
31. Clarke MJ, Erickson D, Castro MR, Atkinson JL (2008) Thyroid-stimulating hormone pituitary adenomas. J Neurosurg 109:17-22. doi: 10.3171/JNS/2008/ 109/7/0017
32. Beck-Peccoz P, Persani L (1994) Variable biological activity of thyroid-stimulating hormone. Eur J Endocrinol 131:331-340
33. Weiss RE, Refetoff S (2000) Resistance to thyroid hormone. Rev Endocr Metab Disord 1:97-108. doi: 10.1023/A:1010072605757
34. Mannavola D, Persani L, Vannuchi G, Zanardelli M, Fugazzola L, Verga U, Facchetti M, Beck-Peccoz P (2005) Different responses to chronic somatostatin analogues in patients with central hyperthyroidism. Clin Endocrinol (Oxf) 62:176-181. doi: 10.1111/j.1365-2265.2004.02192.x
35. Brucker-Davis F, Oldfield EH, Skarulis MC, Doppman JL, Weintraub BD (1999) Thyrotropin-secreting pituitary tumors: Diagnostic criteria, thyroid hormone sensitivity, and treatment outcome in 25 patients followed at the National Institutes of Health. J Clin Endocrinol Metab 84:476-486
36. Sanno N, Teramoto A, Yoshiyuki Osamura R (2001) Thyrotropin-secreting pituitary adenomas. Clinical and biological heterogeneity and current treatment. J Neurooncol 54:179-186. doi: 10.1023/A:1012917701756
37. Valdes Socin H, Chanson P, Delemer B, Tabarin A, Rohmer V, Mockel J, Stevenaert A, Beckers A (2003) The changing spectrum of TSH-secreting pituitary adenomas: Diagnosis and management in 43 patients. Eur J Endocrinol 148:433-442. doi: 10.1530/eje.0.1480433
38. Chanson P, Weintraub BD, Harris AG (1993) Octreotide therapy for thyroid-stimulating hormone-secreting pituitary adenomas: A follow-up of 52 patients. Ann Intern Med 119:236-240
39. Kuhn JM, Arlot S, Levebre H, Caron P, Cortet-Rudelli C, Archambaud F, Chanson P, Tabarin A, Goth MI, Blumberg J, Catus F, Ispas S, Beck-Peccoz P (2000) Evaluation of the treatment of thyrotropin-secreting pituitary adenomas with a slow release formulation of the somatostatin analog Lanreotide. J Clin Endocrinol Metab 85:1487-1491. doi: 10.1210/ jc.85.4.1487
40. Caron P, Arlot S, Bauters C, Chanson P, Kuhn JM, Pugeat M, Marechaud R, Teutsch C, Vidal E, Sassano P (2001) Efficacy of the long-acting octreotide formulation (Octreotide-Lar) in patients with thyrotropin-secreting pituitary adenomas. J Clin Endocrinol Metab 85:1487-1491
41. Kienitz T, Quinkler M, Strasburger CJ, Ventz M (2007) Long-term management in five cases of TSH-secreting pituitary adenomas: A single center study and review of the literature. Eur J Endocrinol 157:39-46. doi: 10.1530/EJE-07-0098
42. Abs R, Stevenaert A, Beckers A (1994) Autonomously functioning thyroid nodules in a patient with a thyrotropin-secreting pituitary adenoma: possible cause-effect relationship. Eur J Endocrinol 131:355-358
43. Samuels MH, Wood WM, Gordon DF, Kleinschmidt-DeMasters BK, Lillehei K, Ridgway EC (1989) Clinical and molecular studies of a thyrotropin-secreting pituitary adenoma. J Clin Endocrinol Metab 68:1211-1215
44. Samuels MH, Henry P, Kleinschmidt-Demasters BK, Lillehei K, Ridgway EC (1991) Pulsatile glycoprotein hormone secretion in glycoprotein-producing pituitary tumors. J Clin Endocrinol Metab 73:1281-1288
45. Beckers A, Abs R, Mahler C, Vandalem JL, Pirens G, Hennen G, Stevenaert A (1991) Thyrotropin-secreting pituitary adenomas: Report of seven cases. J Clin Endocrinol Metab 72:477-483
46. Adriaanse R, Brabant G, Endert E, Bemelman FJ, Wiersinga WM (1994) Pulsatile thyrotropin and prolactin secretion in a patient with a mixed thyrotropin- and prolactin-secreting pituitary adenoma. Eur J Endocrinol 130:113-120
47. Terzolo M, Orlandi F, Bassetti M, Medri G, Paccotti P, Cortelazzi D, Angeli A, Beck-Peccoz P (1991) Hyperthyroidism due to a pituitary adenoma composed of two different cell types, one secreting alpha-subunit alone and another one cosecreting alpha-subunit and thyrotropin. J Clin Endocrinol Metab 72:415-421
48. Bonnefont X, Lacampagne A, Sanchez-Hormigo A, Fino E, Creff A, Mathieu MN, Smallwood S, Carmignac D, Fontanaud P, Travo P, Alonso G, Courtois-Coutry N, Pincus SM, Robinson IC, Mollard P (2005) Revealing the large-scale network organization of growth hormone-secreting cells. Proc Natl Acad Sci USA 102:16880-16885. doi: 10.1073/pnas.0508202102
49. Denef C (2008) Paracrinicity: The story of 30 years of cellular pituitary crosstalk. J Neuroendocrinol 20:1-70. doi: 10.1111/ j.1365-2826.2008.01676.x
50. Devnath S, Inoue K (2008) An insight to pituitary folliculo-stellate cells. J Neuroendocrinol 20:687-691. doi: 10.1111/ j.1365-2826.2008.01716.x
51. Horvath E, Kovacs K (2002) Folliculo-stellate cells of the human pituitary: A type of adult stem cell? Ultrastruct Pathol 26:219-228. doi: 10.1080/01913120290104476
52. Sato G, Shirasawa N, Sakuma E, Sato Y, Asai Y, Wada I, Horiuchi O, Sakamoto A, Herbert DC, Soji T (2005) Intercellular communications within the rat anterior pituitary XI: An immunohistochemical study of distributions of S-100 positive cells in the anterior pituitary of the rat. Tissue Cell 37:269-280. doi: 10.1016/j.tice.2005.03.004
53. Tachibana O, Yamashima T (1988) Immunohistochemical study of folliculo-stellate cells in human pituitary adenomas. Acta Neuropathol 76:458-464. doi: 10.1007/BF00686384